SanBio Company Limited (OTCMKTS:SNBIF) Short Interest Up 19.6% in February

SanBio Company Limited (OTCMKTS:SNBIF) was the target of a significant growth in short interest in the month of February. As of February 27th, there was short interest totaling 1,533,629 shares, a growth of 19.6% from the February 12th total of 1,282,295 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio is currently ∞ days. Based on an average daily volume of 0 shares, the days-to-cover ratio is currently ∞ days.

SanBio Price Performance

OTCMKTS SNBIF opened at C$10.11 on Monday. The company has a fifty day simple moving average of C$10.11 and a 200 day simple moving average of C$16.76. SanBio has a 12-month low of C$4.65 and a 12-month high of C$23.00.

Wall Street Analysts Forecast Growth

Separately, UBS Group began coverage on shares of SanBio in a research report on Sunday, December 14th. They set a “neutral” rating on the stock. One investment analyst has rated the stock with a Hold rating, According to MarketBeat, SanBio currently has a consensus rating of “Hold”.

SanBio Company Profile

SanBio Inc is a clinical‐stage regenerative medicine company focused on developing proprietary cell therapies to address central nervous system disorders. The company’s core technology is based on modulating the brain’s innate repair mechanisms through the transplantation of adult stem cells, with the goal of restoring neurological function in patients suffering from conditions such as stroke, traumatic brain injury and neurodegenerative diseases.

The company’s lead product candidate, SB623, is an investigational cell therapy for chronic motor deficits following ischemic stroke.